Spire Wealth Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-46
Closed -$4.78K 2413
2023
Q1
$4.78K Buy
46
+26
+130% +$2.51K ﹤0.01% 2043
2022
Q4
$2K Buy
+20
New +$1.66K ﹤0.01% 2024

Other funds holding CNMD

Spire Wealth Management's CNMD Position: Q2 2023 in Review

Spire Wealth Management sold out of CONMED (CNMD) in Q2 2023, closing a stake of 46 shares — an estimated $4.78K sold.

Spire Wealth Management first reported a position in CNMD in Q4 2022 and held it in 2 quarters. The position peaked at $4.78K in Q1 2023. 263 funds tracked by Wall St. Rank hold CNMD as of Q2 2023.

  • Spire Wealth Management reported no remaining CONMED position as of Q2 2023 after selling out during the quarter.
  • Spire Wealth Management sold 46 CONMED shares in Q2 2023, an estimated $4.78K.
  • Spire Wealth Management first reported a position in CONMED in Q4 2022 and held it in 2 quarters.
  • Spire Wealth Management's CONMED position peaked at $4.78K in Q1 2023.
  • 263 funds tracked by Wall St. Rank held CONMED as of Q2 2023.

Based on Spire Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.